Stock Market & Financial Investment News

BGI-Shenzhen and Complete Genomics get CFIUS okay for acquisition BGI-Shenzhen and Complete Genomics announced that they have obtained clearance from the Committee on Foreign Investment in the United States, CFIUS, regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, among BGI, Beta Acquisition Corporation and Complete.